Norimichi Kan
About
In The Last Decade
Norimichi Kan
34 papers receiving 332 citations
Peers
Comparison fields: 5 of 55
- Pulmonary and Respiratory Medicine 143
- Oncology 136
- Surgery 113
- Immunology 84
- Pathology and Forensic Medicine 44
Countries citing papers authored by Norimichi Kan
This map shows the geographic impact of Norimichi Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norimichi Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norimichi Kan more than expected).
Fields of papers citing papers by Norimichi Kan
This network shows the impact of papers produced by Norimichi Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norimichi Kan. The network helps show where Norimichi Kan may publish in the future.
Co-authorship network of co-authors of Norimichi Kan
This figure shows the co-authorship network connecting the top 25 collaborators of Norimichi Kan. A scholar is included among the top collaborators of Norimichi Kan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norimichi Kan. Norimichi Kan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | [Effective therapeutic regimens for patients with triple-negative (ER/PgR/HER2-negative) metastatic breast cancer]. | 4 |
| 4 | Treatment with Doxifluridine, Medroxyprogesterone Acetate, and Cyclophosphamide for Supraclavicular Lymph Node Metastasis from Breast Cancer. | 1 |
| 5 | 1 | |
| 6 | 5 | |
| 7 | 42 | |
| 8 | 3 | |
| 9 | 7 | |
| 10 | 1 | |
| 11 | 5 | |
| 12 | 13 | |
| 13 | 7 | |
| 14 | 91 | |
| 15 | 9 | |
| 16 | 15 | |
| 17 | [Experimental study on the optimal treatment schedule for combination of BRM (immunostimulators, cultured killer cells or interleukin-2) and chemotherapy]. | 1 |
| 18 | 3 | |
| 19 | 11 | |
| 20 | Protective effect of vitamin E against immunosuppression induced by adriamycin, mitomycin C and 5-fluorouracil in mice. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.